Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. News
  7. Summary
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sino Biopharmaceutical : China Approves Sino Biopharm's Liver Cancer Drug

07/27/2021 | 01:14am EDT


ę MT Newswires 2021
All news about SINO BIOPHARMACEUTICAL LIMITED
09/13SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for quarterly dividend
FA
09/02SINO BIOPHARMACEUTICAL : Receives Registration Approval for Cancer Treatment in China
MT
09/02SINO BIOPHARMACEUTICAL : Gets Registration Approval for Hepatitis Treatment in China
MT
09/01Hong Kong Hang Seng Rises 0.6%, Led by Tech Sector
MT
09/01Sino Biopharmaceutical Limited Announces Sofosbuvir Tablets Obtains Drug Registration C..
CI
09/01Sino Biopharmaceutical Limited's Lenvatinib Mesilate Capsule Obtains Drug Registration ..
CI
08/31Sino Biopharmaceutical Limited Announces Second Ordinary Interim Dividend for the Finan..
CI
08/31Sino Biopharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30..
CI
08/19Hong Kong Hang Seng Down 2.1% on Beijing Regulatory Outlook
MT
08/18Sino Biopharmaceutical Limited Provides Earnings Guidance for the Six Months Ended 30 J..
CI
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIMITED
More recommendations
Financials
Sales 2021 34 304 M 4 405 M 4 405 M
Net income 2021 10 387 M 1 334 M 1 334 M
Net cash 2021 10 050 M 1 291 M 1 291 M
P/E ratio 2021 12,3x
Yield 2021 2,06%
Capitalization 117 B 15 015 M 15 017 M
EV / Sales 2021 3,12x
EV / Sales 2022 2,48x
Nbr of Employees 24 443
Free-Float 52,3%
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 6,23 HKD
Average target price 10,65 HKD
Spread / Average Target 70,9%
EPS Revisions
Managers and Directors
Yi Li Chief Executive Officer & Executive Director
Theresa Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Mao Li Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
SINO BIOPHARMACEUTICAL LIMITED-16.93%15 015
JOHNSON & JOHNSON4.54%433 122
ROCHE HOLDING AG9.82%321 584
PFIZER, INC.20.08%246 246
NOVO NORDISK A/S52.07%234 070
ELI LILLY AND COMPANY36.32%208 668